Tracking 500 cancer patients to map Real-World treatment results
NCT ID NCT07296627
Summary
This study aims to understand how newly diagnosed multiple myeloma patients in China respond to first-line immunotherapy treatments in everyday medical practice. Researchers will follow 500 patients for one year to collect information about their treatment choices, how well the treatments work, and patient outcomes. The goal is to gather real-world evidence that can help doctors make better treatment decisions for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.